Skip to content

Research at St Andrews

Mycobacterial load assay

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Tuberculosis is a difficult disease to treat, a process made more harder as tools to monitor treatment response only provide a result long after the patient has provided a sample. The mycobacterial load assay (MBLA) provides a simple molecular test to quantify and determine the viability of M. tuberculosis in human or other samples.

Close

Details

Original languageEnglish
Title of host publicationDiagnostic Bacteriology
Subtitle of host publicationMethods and Protocols
EditorsKimberley A. Bishop-Lilly
Place of PublicationNew York, NY
PublisherHumana Press/Springer
Pages89-105
Number of pages17
ISBN (Electronic)9781493970377
ISBN (Print)9781493970353
DOIs
StatePublished - 2017

Publication series

NameMethods in Molecular Biology
Volume1616
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

    Research areas

  • Mycobacterial load assay (MBLA), Sputum, Ribosomal RNA (rRNA), Reverse transcriptase real-time quantitative polymerase chain reaction (RT-qPCR)

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. OMNIgene.SPUTUM suppresses contaminants whilst maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport

    Azam, K., Cadir, N., Madeira, C., Gillespie, S. H. & Sabiiti, W. 16 Feb 2018 In : ERJ Open Research. 4, 8 p., 00074-2017

    Research output: Contribution to journalArticle

  2. Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings

    Sabiiti, W. , Mtafya, B. , Kuchaka, D. , Azam, K. , Viegas, S. , Mdolo, A. , Farmer, E. , Khonga, M. , Evangelopoulos, D. , Honeyborne, I. , Rachow, A. , Heinrich, N. , Ntinginya, N. E. , Bhatt, N. , Davies, G. R. , Jani, I. V. , McHugh, T. D. , Kibiki, G. , Hoelscher, M. , Gillespie, S. H. & 1 others on behalf of the PANBIOME (Pan-African Biomarker Expansion Programme) consortium 1 Aug 2016 In : International Journal of Tuberculosis and Lung Disease. 20, 8, p. 1004-1009

    Research output: Contribution to journalArticle

  3. Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Crook, A. M., Amukoye, E. I., Dawson, R., Diacon, A. H., Hanekom, M., McHugh, T. D., Mendel, C. M., Meredith, S. K., Murphy, M. E., Murthy, S. E., Nunn, A. J., Phillips, P. P. J., Singh, K. P., Spigelman, M., Wills, G. H. & Gillespie, S. H. 11 Jul 2018 In : BMC Infectious Diseases. 18, 11 p., 317

    Research output: Contribution to journalArticle

  4. Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis: in the Cornell mouse model

    Liu, Y., Pertinez, H., Davies, G. R., Gillespie, S. H., Coates, A. R. & Hu, Y. Jul 2018 In : Antimicrobial Agents and Chemotherapy. 62, 7, 9 p., e00190-18

    Research output: Contribution to journalArticle

  5. Forecasting clinical dose-response from pre-clinical studies in tuberculosis research - translational predictions with rifampicin

    Wicha, S. G., Clewe, O., Svensson, R. J., Gillespie, S. H., Hu, Y., Coates, A. R. & Simonsson, U. S. 19 Jun 2018 In : Clinical Pharmacology & Therapeutics. Early View

    Research output: Contribution to journalArticle

ID: 250685143